Head, Neck Imaging Uncommon in Patients With Palate Trauma

Share this content:
Head, Neck Imaging Uncommon in Patients With Palate Trauma
Head, Neck Imaging Uncommon in Patients With Palate Trauma

TUESDAY, Feb. 6, 2018 (HealthDay News) -- Patients presenting to the emergency department with a primary diagnosis of palate trauma often do not undergo head and neck imaging, according to a study published online Feb. 1 in JAMA Otolaryngology-Head and Neck Surgery.

Aaron Smith, M.D., from the University of Tennessee Health Science Center in Memphis, and colleagues conducted a retrospective analysis of 22,094 patients with a primary diagnosis of palate trauma presenting to U.S. emergency departments during 2006 to 2010.

The researchers found that during the five-year study period, there was a decrease in total hospital visits from 1.58 to 1.26 per 100,000 people. Overall, 89.7 percent of patients had routine discharge from the hospital, while palate repair and mortality were rare (4.4 and 0.2 percent, respectively). Admission occurred infrequently (4.6 percent); the likelihood was increased with complicated palate trauma, male sex, codiagnosis status, and residence in the Northeast versus the South (odds ratios, 5.32, 1.57, 2.75, and 2.73, respectively). Head and neck imaging occurred in 11.9 percent of patients after restriction to reliable Current Procedural Terminology coding facilities. Living in a medium versus large metropolitan area was correlated with imaging (odds ratio, 1.62), while a negative correlation was seen for living in the Midwest versus the South (odds ratio, 0.43).

"Although it is often suggested in the otolaryngology literature to perform imaging, primary palate trauma usually results in a routine discharge home without imaging or repair," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »